HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia
HDAC7诱导联合标准治疗化疗在t(4;11)婴儿B细胞急性淋巴细胞白血病中具有治疗优势。
期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-025-00810-1
de Barrios, Oriol; Ocón-Gabarró, Ingrid; Gusi-Vives, Mar; Collazo, Olga; Meler, Ainara; Romecín, Paola A; Martínez-Moreno, Alba; Tejedor, Juan Ramón; Fraga, Mario F; Schneider, Pauline; Bardini, Michela; Cazzaniga, Giovanni; Marschalek, Rolf; Stam, Ronald W; Bueno, Clara; Menéndez, Pablo; Parra, Maribel